Report Detail

Request for Sample of this report

Pharma & Healthcare Global Lipid-lowering Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032

  • RnM4743388
    • |
  • 28 September, 2026
    • |
  • Global
    • |
  • 123 Pages
    • |
  • GIR
    • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Lipid-lowering Drugs market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Lipid-lowering Drugs market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Lipid-lowering Drugs market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Lipid-lowering Drugs market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Lipid-lowering Drugs market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Lipid-lowering Drugs market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Lipid-lowering Drugs
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Lipid-lowering Drugs market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Sanofi, Pfizer, Inc., GlaxoSmithKline plc, Novartis AG, Merck & Co., Inc., Amgen Inc., Takeda Pharmaceutical Company Limited, Sun Pharmaceutical Industries Ltd., AbbVie, Inc., Viatris (Mylan N.V.), etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Lipid-lowering Drugs market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Statins & Combination
PCSK9 Inhibitors
Bile Acid Sequestrants
Fibrates
Cholesterol Absorption Inhibitors
Others
Market segment by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Major players covered
Sanofi
Pfizer, Inc.
GlaxoSmithKline plc
Novartis AG
Merck & Co., Inc.
Amgen Inc.
Takeda Pharmaceutical Company Limited
Sun Pharmaceutical Industries Ltd.
AbbVie, Inc.
Viatris (Mylan N.V.)
AstraZeneca PLC
Dr. Reddy’s Laboratories Ltd.
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Lipid-lowering Drugs product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Lipid-lowering Drugs, with price, sales quantity, revenue, and global market share of Lipid-lowering Drugs from 2021 to 2026.
Chapter 3, the Lipid-lowering Drugs competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Lipid-lowering Drugs breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Lipid-lowering Drugs market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Lipid-lowering Drugs.
Chapter 14 and 15, to describe Lipid-lowering Drugs sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Lipid-lowering Drugs Consumption Value by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Statins & Combination
    • 1.3.3 PCSK9 Inhibitors
    • 1.3.4 Bile Acid Sequestrants
    • 1.3.5 Fibrates
    • 1.3.6 Cholesterol Absorption Inhibitors
    • 1.3.7 Others
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Lipid-lowering Drugs Consumption Value by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospital Pharmacies
    • 1.4.3 Retail Pharmacies
    • 1.4.4 Online Pharmacies
  • 1.5 Global Lipid-lowering Drugs Market Size & Forecast
    • 1.5.1 Global Lipid-lowering Drugs Consumption Value (2021 & 2025 & 2032)
    • 1.5.2 Global Lipid-lowering Drugs Sales Quantity (2021-2032)
    • 1.5.3 Global Lipid-lowering Drugs Average Price (2021-2032)

2 Manufacturers Profiles

  • 2.1 Sanofi
    • 2.1.1 Sanofi Details
    • 2.1.2 Sanofi Major Business
    • 2.1.3 Sanofi Lipid-lowering Drugs Product and Services
    • 2.1.4 Sanofi Lipid-lowering Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Sanofi Recent Developments/Updates
  • 2.2 Pfizer, Inc.
    • 2.2.1 Pfizer, Inc. Details
    • 2.2.2 Pfizer, Inc. Major Business
    • 2.2.3 Pfizer, Inc. Lipid-lowering Drugs Product and Services
    • 2.2.4 Pfizer, Inc. Lipid-lowering Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Pfizer, Inc. Recent Developments/Updates
  • 2.3 GlaxoSmithKline plc
    • 2.3.1 GlaxoSmithKline plc Details
    • 2.3.2 GlaxoSmithKline plc Major Business
    • 2.3.3 GlaxoSmithKline plc Lipid-lowering Drugs Product and Services
    • 2.3.4 GlaxoSmithKline plc Lipid-lowering Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 GlaxoSmithKline plc Recent Developments/Updates
  • 2.4 Novartis AG
    • 2.4.1 Novartis AG Details
    • 2.4.2 Novartis AG Major Business
    • 2.4.3 Novartis AG Lipid-lowering Drugs Product and Services
    • 2.4.4 Novartis AG Lipid-lowering Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 Novartis AG Recent Developments/Updates
  • 2.5 Merck & Co., Inc.
    • 2.5.1 Merck & Co., Inc. Details
    • 2.5.2 Merck & Co., Inc. Major Business
    • 2.5.3 Merck & Co., Inc. Lipid-lowering Drugs Product and Services
    • 2.5.4 Merck & Co., Inc. Lipid-lowering Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 Merck & Co., Inc. Recent Developments/Updates
  • 2.6 Amgen Inc.
    • 2.6.1 Amgen Inc. Details
    • 2.6.2 Amgen Inc. Major Business
    • 2.6.3 Amgen Inc. Lipid-lowering Drugs Product and Services
    • 2.6.4 Amgen Inc. Lipid-lowering Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Amgen Inc. Recent Developments/Updates
  • 2.7 Takeda Pharmaceutical Company Limited
    • 2.7.1 Takeda Pharmaceutical Company Limited Details
    • 2.7.2 Takeda Pharmaceutical Company Limited Major Business
    • 2.7.3 Takeda Pharmaceutical Company Limited Lipid-lowering Drugs Product and Services
    • 2.7.4 Takeda Pharmaceutical Company Limited Lipid-lowering Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates
  • 2.8 Sun Pharmaceutical Industries Ltd.
    • 2.8.1 Sun Pharmaceutical Industries Ltd. Details
    • 2.8.2 Sun Pharmaceutical Industries Ltd. Major Business
    • 2.8.3 Sun Pharmaceutical Industries Ltd. Lipid-lowering Drugs Product and Services
    • 2.8.4 Sun Pharmaceutical Industries Ltd. Lipid-lowering Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Sun Pharmaceutical Industries Ltd. Recent Developments/Updates
  • 2.9 AbbVie, Inc.
    • 2.9.1 AbbVie, Inc. Details
    • 2.9.2 AbbVie, Inc. Major Business
    • 2.9.3 AbbVie, Inc. Lipid-lowering Drugs Product and Services
    • 2.9.4 AbbVie, Inc. Lipid-lowering Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 AbbVie, Inc. Recent Developments/Updates
  • 2.10 Viatris (Mylan N.V.)
    • 2.10.1 Viatris (Mylan N.V.) Details
    • 2.10.2 Viatris (Mylan N.V.) Major Business
    • 2.10.3 Viatris (Mylan N.V.) Lipid-lowering Drugs Product and Services
    • 2.10.4 Viatris (Mylan N.V.) Lipid-lowering Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Viatris (Mylan N.V.) Recent Developments/Updates
  • 2.11 AstraZeneca PLC
    • 2.11.1 AstraZeneca PLC Details
    • 2.11.2 AstraZeneca PLC Major Business
    • 2.11.3 AstraZeneca PLC Lipid-lowering Drugs Product and Services
    • 2.11.4 AstraZeneca PLC Lipid-lowering Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.11.5 AstraZeneca PLC Recent Developments/Updates
  • 2.12 Dr. Reddy’s Laboratories Ltd.
    • 2.12.1 Dr. Reddy’s Laboratories Ltd. Details
    • 2.12.2 Dr. Reddy’s Laboratories Ltd. Major Business
    • 2.12.3 Dr. Reddy’s Laboratories Ltd. Lipid-lowering Drugs Product and Services
    • 2.12.4 Dr. Reddy’s Laboratories Ltd. Lipid-lowering Drugs Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
    • 2.12.5 Dr. Reddy’s Laboratories Ltd. Recent Developments/Updates

3 Competitive Environment: Lipid-lowering Drugs by Manufacturer

  • 3.1 Global Lipid-lowering Drugs Sales Quantity by Manufacturer (2021-2026)
  • 3.2 Global Lipid-lowering Drugs Revenue by Manufacturer (2021-2026)
  • 3.3 Global Lipid-lowering Drugs Average Price by Manufacturer (2021-2026)
  • 3.4 Market Share Analysis (2025)
    • 3.4.1 Producer Shipments of Lipid-lowering Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2025
    • 3.4.2 Top 3 Lipid-lowering Drugs Manufacturer Market Share in 2025
    • 3.4.3 Top 6 Lipid-lowering Drugs Manufacturer Market Share in 2025
  • 3.5 Lipid-lowering Drugs Market: Overall Company Footprint Analysis
    • 3.5.1 Lipid-lowering Drugs Market: Region Footprint
    • 3.5.2 Lipid-lowering Drugs Market: Company Product Type Footprint
    • 3.5.3 Lipid-lowering Drugs Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Lipid-lowering Drugs Market Size by Region
    • 4.1.1 Global Lipid-lowering Drugs Sales Quantity by Region (2021-2032)
    • 4.1.2 Global Lipid-lowering Drugs Consumption Value by Region (2021-2032)
    • 4.1.3 Global Lipid-lowering Drugs Average Price by Region (2021-2032)
  • 4.2 North America Lipid-lowering Drugs Consumption Value (2021-2032)
  • 4.3 Europe Lipid-lowering Drugs Consumption Value (2021-2032)
  • 4.4 Asia-Pacific Lipid-lowering Drugs Consumption Value (2021-2032)
  • 4.5 South America Lipid-lowering Drugs Consumption Value (2021-2032)
  • 4.6 Middle East & Africa Lipid-lowering Drugs Consumption Value (2021-2032)

5 Market Segment by Type

  • 5.1 Global Lipid-lowering Drugs Sales Quantity by Type (2021-2032)
  • 5.2 Global Lipid-lowering Drugs Consumption Value by Type (2021-2032)
  • 5.3 Global Lipid-lowering Drugs Average Price by Type (2021-2032)

6 Market Segment by Application

  • 6.1 Global Lipid-lowering Drugs Sales Quantity by Application (2021-2032)
  • 6.2 Global Lipid-lowering Drugs Consumption Value by Application (2021-2032)
  • 6.3 Global Lipid-lowering Drugs Average Price by Application (2021-2032)

7 North America

  • 7.1 North America Lipid-lowering Drugs Sales Quantity by Type (2021-2032)
  • 7.2 North America Lipid-lowering Drugs Sales Quantity by Application (2021-2032)
  • 7.3 North America Lipid-lowering Drugs Market Size by Country
    • 7.3.1 North America Lipid-lowering Drugs Sales Quantity by Country (2021-2032)
    • 7.3.2 North America Lipid-lowering Drugs Consumption Value by Country (2021-2032)
    • 7.3.3 United States Market Size and Forecast (2021-2032)
    • 7.3.4 Canada Market Size and Forecast (2021-2032)
    • 7.3.5 Mexico Market Size and Forecast (2021-2032)

8 Europe

  • 8.1 Europe Lipid-lowering Drugs Sales Quantity by Type (2021-2032)
  • 8.2 Europe Lipid-lowering Drugs Sales Quantity by Application (2021-2032)
  • 8.3 Europe Lipid-lowering Drugs Market Size by Country
    • 8.3.1 Europe Lipid-lowering Drugs Sales Quantity by Country (2021-2032)
    • 8.3.2 Europe Lipid-lowering Drugs Consumption Value by Country (2021-2032)
    • 8.3.3 Germany Market Size and Forecast (2021-2032)
    • 8.3.4 France Market Size and Forecast (2021-2032)
    • 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
    • 8.3.6 Russia Market Size and Forecast (2021-2032)
    • 8.3.7 Italy Market Size and Forecast (2021-2032)

9 Asia-Pacific

  • 9.1 Asia-Pacific Lipid-lowering Drugs Sales Quantity by Type (2021-2032)
  • 9.2 Asia-Pacific Lipid-lowering Drugs Sales Quantity by Application (2021-2032)
  • 9.3 Asia-Pacific Lipid-lowering Drugs Market Size by Region
    • 9.3.1 Asia-Pacific Lipid-lowering Drugs Sales Quantity by Region (2021-2032)
    • 9.3.2 Asia-Pacific Lipid-lowering Drugs Consumption Value by Region (2021-2032)
    • 9.3.3 China Market Size and Forecast (2021-2032)
    • 9.3.4 Japan Market Size and Forecast (2021-2032)
    • 9.3.5 South Korea Market Size and Forecast (2021-2032)
    • 9.3.6 India Market Size and Forecast (2021-2032)
    • 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
    • 9.3.8 Australia Market Size and Forecast (2021-2032)

10 South America

  • 10.1 South America Lipid-lowering Drugs Sales Quantity by Type (2021-2032)
  • 10.2 South America Lipid-lowering Drugs Sales Quantity by Application (2021-2032)
  • 10.3 South America Lipid-lowering Drugs Market Size by Country
    • 10.3.1 South America Lipid-lowering Drugs Sales Quantity by Country (2021-2032)
    • 10.3.2 South America Lipid-lowering Drugs Consumption Value by Country (2021-2032)
    • 10.3.3 Brazil Market Size and Forecast (2021-2032)
    • 10.3.4 Argentina Market Size and Forecast (2021-2032)

11 Middle East & Africa

  • 11.1 Middle East & Africa Lipid-lowering Drugs Sales Quantity by Type (2021-2032)
  • 11.2 Middle East & Africa Lipid-lowering Drugs Sales Quantity by Application (2021-2032)
  • 11.3 Middle East & Africa Lipid-lowering Drugs Market Size by Country
    • 11.3.1 Middle East & Africa Lipid-lowering Drugs Sales Quantity by Country (2021-2032)
    • 11.3.2 Middle East & Africa Lipid-lowering Drugs Consumption Value by Country (2021-2032)
    • 11.3.3 Turkey Market Size and Forecast (2021-2032)
    • 11.3.4 Egypt Market Size and Forecast (2021-2032)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
    • 11.3.6 South Africa Market Size and Forecast (2021-2032)

12 Market Dynamics

  • 12.1 Lipid-lowering Drugs Market Drivers
  • 12.2 Lipid-lowering Drugs Market Restraints
  • 12.3 Lipid-lowering Drugs Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Lipid-lowering Drugs and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Lipid-lowering Drugs
  • 13.3 Lipid-lowering Drugs Production Process
  • 13.4 Industry Value Chain Analysis

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Lipid-lowering Drugs Typical Distributors
  • 14.3 Lipid-lowering Drugs Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Lipid-lowering Drugs. Industry analysis & Market Report on Lipid-lowering Drugs is a syndicated market report, published as Global Lipid-lowering Drugs Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Lipid-lowering Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    		$3,480.00
    		$5,220.00
    		$6,960.00
    		2,690.04
    		4,035.06
    		5,380.08
    		3,239.88
    		4,859.82
    		6,479.76
    		531,361.20
    		797,041.80
    		1,062,722.40
    		293,712.00
    		440,568.00
    		587,424.00
    Credit card Logo
    Sample Question Discount Download PDF

    Related Reports

    Reason to Buy

    • Trusted By Leaders

      Top executives from leading companies purchase research reports from us. 

    • Shop With Confidence

      We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

    • Customer Centric

      Need assistance related to your research requirements? We are just a phone call or an email away.

    • Personalized Solutions

      Our experienced research specialists are here to help you locate the right reports for your need.

    • Secure Checkout

      Shop without being worried about safety & security of your transactions.
      •

    Request for Sample of this report

    Reports and Markets

    mcafree

    Contact Us

    +1-352-353-0818 (US)

    info@reportsandmarkets.com

    Support

    EMAIL US

    Newsletter

    KEEP UP TO DATE ON ALL THE LATEST REPORTS


    maxmind_logo